Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

Press releases published on July 29, 2026

an hour ago

VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates

Indeterminate GlobeNewswire

an hour ago

Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center

Indeterminate GlobeNewswire

an hour ago

Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy

Indeterminate GlobeNewswire

an hour ago

Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

Indeterminate GlobeNewswire

an hour ago

Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026

Indeterminate GlobeNewswire

an hour ago

Atavistik Bio Appoints Habib Dable to its Board of Directors

Indeterminate GlobeNewswire

an hour ago

Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe

Indeterminate GlobeNewswire

an hour ago

OPSEU/SEFPO workers at Canadian Blood Services strike a blow against privatization

Indeterminate GlobeNewswire

an hour ago

Bioxytran Announces Publication of Corporate Research Report by Globe Small Cap Research

Indeterminate GlobeNewswire

an hour ago

XORTX Appoints New Director

Indeterminate GlobeNewswire

an hour ago

Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence

Indeterminate GlobeNewswire

an hour ago

Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026

Indeterminate GlobeNewswire

an hour ago

TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies 

Indeterminate GlobeNewswire

an hour ago

TRUE-See Systems Announces New Venture Funding

Indeterminate GlobeNewswire

an hour ago

ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

an hour ago

Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution

Indeterminate GlobeNewswire

an hour ago

MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF

Indeterminate GlobeNewswire

an hour ago

Fortrea Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

2 hours ago

Shape Therapeutics Receives Research Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance SHP-201, a One-Time Gene Therapy to Treat Parkinson’s Disease

Indeterminate GlobeNewswire

2 hours ago

Integra LifeSciences Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire